Regulations.gov document
Agency Information Collection Activities; Proposed Collection; Comment Request…
Notice · FDA-2020-N-2231 · posted Feb 18, 2021
Key facts
| Document ID | FDA-2020-N-2231-0001 |
|---|---|
| Title | Agency Information Collection Activities; Proposed Collection; Comment Request; Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices |
| Document type | Notice |
| Subtype | 60 Day Proposed Information Collection |
| Agency | FDA |
| Docket | FDA-2020-N-2231 |
| Posted | Feb 18, 2021 |
| Federal Register citation | 86 FR 10085 |
| FR document number | 2021-03249 |
| Comment period opens | Feb 18, 2021 |
| Comments due | Apr 20, 2021 |
| Effective date | Feb 18, 2021 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: